REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrum Syntezy Molekul Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Centrum Syntezy Molekul Sp. z o.o. Profile Updated: February 24, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Centrum Syntezy Molekul Sp. z o.o. is an enterprise located in Poland, with the main office in Sieradz. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. Centrum Syntezy Molekul Sp. z o.o. was incorporated on May 23, 2014. 5 (2014) employees currently work for Centrum Syntezy Molekul Sp. z o.o.. There was a total negative growth of 1.82% in Centrum Syntezy Molekul Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Wladyslawa Lokietka 10
Sieradz; Lodzkie; Postal Code: 98-200

Contact Details: Purchase the Centrum Syntezy Molekul Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Centrum Syntezy Molekul Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Centrum Syntezy Molekul Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Centrum Syntezy Molekul Sp. z o.o. report to view the information.
Incorporation Date:
May 23, 2014
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Centrum Syntezy Molekul Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
8827.22%
Operating profit (EBIT)
68.05%
Net Profit (Loss) for the Period
68.05%
Total assets
-1.82%
Total equity
-2.45%
Return on Equity (ROE)
5.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?